Coloplast A/S (OTCMKTS:CLPBY) Sees Unusually-High Trading Volume – Here’s What Happened

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) saw an uptick in trading volume on Monday . 847,664 shares traded hands during mid-day trading, an increase of 47% from the previous session’s volume of 575,459 shares.The stock last traded at $6.36 and had previously closed at $6.30.

Analyst Ratings Changes

Several research firms recently commented on CLPBY. The Goldman Sachs Group lowered Coloplast A/S from a “hold” rating to a “strong sell” rating in a research report on Tuesday, April 7th. Sanford C. Bernstein upgraded Coloplast A/S to a “hold” rating in a research report on Wednesday, January 28th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Coloplast A/S has a consensus rating of “Reduce”.

Coloplast A/S Trading Down 2.2%

The company has a market cap of $14.17 billion, a PE ratio of 19.49, a price-to-earnings-growth ratio of 2.07 and a beta of 0.15. The company has a debt-to-equity ratio of 1.50, a current ratio of 1.30 and a quick ratio of 0.81. The company has a 50-day moving average of $6.74 and a 200 day moving average of $7.98.

Coloplast A/S (OTCMKTS:CLPBY) last released its quarterly earnings results on Tuesday, May 12th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of $0.09 by $0.01. The company had revenue of $1.11 billion during the quarter, compared to analyst estimates of $1.11 billion. Coloplast A/S had a return on equity of 31.96% and a net margin of 7.46%. Analysts predict that Coloplast A/S Sponsored ADR will post 0.39 earnings per share for the current year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.